XML 25 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Marketable Securities
3 Months Ended
Apr. 30, 2024
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities Marketable Securities
The following is a summary of our marketable securities (in thousands): 
As of April 30, 2024
Amortized CostGross Unrealized GainsGross Unrealized LossesEstimated Fair Value
Commercial paper$978 $— $— $978 
Treasury bills and U.S. government securities(1)
710,071 — (506)709,565 
Corporate bonds(2)
24,778 — (60)24,718 
Agency bonds54,661 — (40)54,621 
Total marketable securities$790,488 $— $(606)$789,882 
(1) Additional treasury bills with both amortized cost and estimated fair value of $19.8 million are included in cash and cash equivalents due to their original maturity of three months or less.
(2) Additional corporate bonds with both amortized cost and estimated fair value of $6.1 million are included in cash and cash equivalents due to their original maturity of three months or less.
As of January 31, 2024
Amortized CostGross Unrealized GainsGross Unrealized LossesEstimated Fair Value
Treasury bills and U.S. government securities641,263 29 (100)641,192 
Corporate bonds1,993 — (2)1,991 
Agency bonds174,990 — (28)174,962 
Total marketable securities$818,246 $29 $(130)$818,145 
As of April 30, 2024 and January 31, 2024, $1.0 million and none, respectively, of our marketable securities had remaining contractual maturities of one year or more.
As of April 30, 2024 and January 31, 2024, $3.1 million and $3.3 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of April 30, 2024 and January 31, 2024.
Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.